| |
|
|
|
|
|
|
|||
|
Blood, 15 February 2005, Vol. 105, No. 4, pp. 1476-1483. Prepublished online as a Blood First Edition Paper on October 21, 2004; DOI 10.1182/blood-2004-06-2302.
Submitted June 16, 2004
Hematopoiesis Department, Jerome H. Holland Laboratory for the Biomedical Sciences, American Red Cross, Rockville, MD, USA * Corresponding author; email: kevin.bunting{at}case.edu.
Homologous disruption of STAT5a and STAT5b expression (STAT5ab-/-) in mice results in hematopoietic stem cells (HSCs) that can engraft irradiated hosts alone but are non-competitive against wild-type HSCs. To explore mechanisms for this phenotype, we crossed the STAT5 mutations onto an HW80 background congenic to the original C57BL/6 that differs in a small chromosome 7 genomic locus. C57BL/6 or HW80 background STAT5ab-/- bone marrow (BM) cells showed equal repopulating function either competitively (Bradley et al. Blood 103:2965, 2004) or non-competitively in irradiated hosts. However, one intraperitoneal injection of wild-type green fluorescent protein (GFP) transgenic BM cells into unconditioned newborn STAT5ab-/- recipients of either background was sufficient for high level donor engraftment. Furthermore, haploinsufficiency of STAT5 (STAT5ab+/-) allowed improved engraftment over wild-type recipients, indicating a dose-dependent requirement for STAT5 activation. In reciprocal experiments, STAT5ab-/- BM was transplanted into non-irradiated W/Wv hosts. In these mice, C57BL/6 STAT5ab-/- BM cells were 10-fold more defective in long-term engraftment than control wild-type BM cells and HW80 STAT5ab-/- BM cells were 5- to 10-fold more defective than C57BL/6 STAT5ab-/- BM cells. Therefore, we conclude that STAT5 plays a critical role during steady-state HSC engraftment and a chromosome 7 modifier locus regulates this activity.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2004 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||